Investmark Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.54M | Sell |
24,454
-1,417
| -5% | -$263K | 2.13% | 9 |
|
|
2025
Q1 | $5.42M | Sell |
25,871
-410
| -2% | -$85.9K | 2.68% | 7 |
|
|
2024
Q4 | $4.67M | Buy |
26,281
+189
| +0.7% | +$33.6K | 2.29% | 9 |
|
|
2024
Q3 | $5.15M | Buy |
26,092
+347
| +1% | +$68.5K | 2.5% | 8 |
|
|
2024
Q2 | $4.42M | Sell |
25,745
-287
| -1% | -$49.2K | 2.36% | 9 |
|
|
2024
Q1 | $4.74M | Sell |
26,032
-1,110
| -4% | -$202K | 2.6% | 8 |
|
|
2023
Q4 | $4.21M | Buy |
27,142
+197
| +0.7% | +$30.5K | 2.47% | 9 |
|
|
2023
Q3 | $4.02M | Buy |
26,945
+230
| +0.9% | +$34.3K | 2.72% | 7 |
|
|
2023
Q2 | $3.6M | Buy |
26,715
+150
| +0.6% | +$20.2K | 2.4% | 11 |
|
|
2023
Q1 | $4.23M | Buy |
26,565
+433
| +2% | +$69K | 3.11% | 5 |
|
|
2022
Q4 | $4.22M | Buy |
26,132
+583
| +2% | +$94.2K | 3.13% | 5 |
|
|
2022
Q3 | $3.43M | Buy |
25,549
+607
| +2% | +$81.4K | 3.08% | 5 |
|
|
2022
Q2 | $3.82M | Buy |
24,942
+266
| +1% | +$40.7K | 3.78% | 5 |
|
|
2022
Q1 | $4M | Buy |
24,676
+456
| +2% | +$73.9K | 4.12% | 5 |
|
|
2021
Q4 | $3.28M | Buy |
+24,220
| New | +$3.28M | 3.07% | 8 |
|